Change in plasma s100b level after acute spontaneous basal ganglia hemorrhage

Shock

Volumn 33, Issue 2, 2010, Pages 134-140

  Hu, Yue Yu ^a   Dong, Xiao Qiao ^b   Yu, Wen Hua ^b   Zhang, Zu Yong ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b The First Hangzhou Municipal People's Hospital   (China)

Author keywords

Biomarkers; Inflammatory reaction; Intracerebral hemorrhage; Prognosis; S100B; Stroke

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; HISTAMINE H2 RECEPTOR ANTAGONIST; MANNITOL; PROTEIN S100B;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BASAL GANGLION HEMORRHAGE; BLOOD SAMPLING; BLOOD VOLUME; BRAIN DECOMPRESSION; BRAIN HEMORRHAGE; BRAIN SURGERY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLASGOW COMA SCALE; HUMAN; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSIOTHERAPY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; S100B BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

AGED; BASAL GANGLIA HEMORRHAGE; CEREBRAL HEMORRHAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; HUMANS; MALE; MIDDLE AGED; S100 PROTEINS;

EID: 77649117534     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181ad5c88     Document Type: Article

References (25)

1. Barger SW, Van Eldik LJ: S100 beta stimulates calcium fluxes in glial and neuronal cells. J Biol Chem 267:9689-9694, 1992.
2. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33:637-668, 2001.
3. Hu J, Castets F, Guevara JL, Van Eldik LJ: S100" stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J Biol Chem 271:2543-2547, 1996.
4. Hu J, Ferreira A, Van Eldik LJ: S100" induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem 69:2294-2301, 1997.
5. Foerch C, Singer OC, Neumann-Haefelin T, du Mesnil de Rochemont R, Steinmetz H, Sitzer M: Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 62:1130-1134, 2005.
6. Hayakata T, Shiozaki T, Tasaki O, Ikegawa H, Inoue Y, Toshiyuki F, Hosotubo H, Kieko F, Yamashita T, Tanaka H, et al.: Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 22:102-107, 2004.
7. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J: The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304-1305, 1996.
8. Gujjar AR, Deibert E, Manno EM, Duff S, Diringer MN: Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology 51:447-451, 1998.
9. Butcher K, Laidlaw J: Current intracerebral haemorrhage management. J Clin Neurosci 10:158-167, 2003.
10. Donato R: Functional roles of S100B proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1450:191-231, 1999.
11. Van Eldik LJ, Wainwright MS: The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 21:97-108, 2003.
12. Pinto SS, Gottfried C, Mendez A, Gonçalves D, Karl J, Gonçalves CA, Wofchuk S, Rodnight R: Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology. FEBS Lett 486:203-207, 2000.
13. Whitaker-Azmitia PM, Murphy R, Azmitia EC: Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res 528:155-158, 1990.
14. Kim SH, Smith CJ, Van Eldik LJ: Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol Aging 25:431-439, 2004.
15. Ponath G, Schettler C, Kaestner F, Voigt B, Wentker D, Arolt V, Rothermundt M: Autocrine S100B effects on astrocytes are mediated via RAGE. J Neuroimmunol 184:214-222, 2007.
16. Hu J, Castets F, Guevara JL, Van Eldik LJ: S100" stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J Biol Chem 271:2543-2547, 1996.
17. Liu L, Li Y, Van Eldik LJ, Griffin WS, Barger SW: S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. J Neurochem 92:546-553, 2005.
18. Griffin WS, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE: Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol 8:65-72, 1998.
19. Mori T, Tan J, Arendash GW, Koyama N, Nojima Y, Town T: Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia. Stroke 39:2114-2121, 2008.
20. Lam AG, Koppal T, Akama KT, Guo L, Graft JM, Samy B, Schavocky JP, Watterson DM, Yan Eldik LJ: Mechanism of glial activation by S100B: involvement of the transcription factor NF.B. Neurobiol Aging 22:765-772, 2001.
21. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, et al.: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901, 1999.
22. Li J, Schmidt AM: Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272:16498-16506, 1997.
23. Robson SC, Shephard EG, Kirsch RE: Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86:322-326, 1994.
24. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR: Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 37:800-805, 1995.
25. Maresca G, Di Blasio A, Marchioli R, Di Minno G: Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 19:1368-1377, 1999.